Skip to section navigation
Skip to page content

Publications from RAND Health Care Researchers

Temporary Safety-Net Policies and Pandemic-Related Insurance Loss in New York State 2021

Christine Eibner, Jodi L. Liu, Carter C. Price, Nabeel Qureshi, Raffaele Vardavas
The coronavirus disease 2019 pandemic–related recession and resulting job loss raised significant concerns that the U.S. uninsured population could increase, perhaps by millions. However, worrisome predictions about coverage loss have not materialized. RAND researchers (1) assess the importance of temporary provisions in stabilizing health insurance enrollment despite heavy job loss and (2) run simulations using New York state as a case study.
Twenty-Six Veterans: A Longitudinal Case Study of Veterans Experiencing Homelessness in Los Angeles, 2019–2020 2021

Sarah B. Hunter, Benjamin F. Henwood, Rajeev Ramchand, Stephanie Brooks Holliday, Rick Garvey
Veteran homelessness in Los Angeles is a pervasive public health and social problem. In this report, the authors describe a first-of-its-kind longitudinal study conducted in 2019/2020 that followed 26 veterans experiencing homelessness in Los Angeles. The authors use the information provided by veterans about their housing, health, and service experiences to identify factors related to engaging in care and attaining stable housing.
Money and My Mind: Maternal Cash Transfers and Mental Health 2021

Edward N. Okeke
This paper documents important mental health spillovers in the context of a program that offered pregnant women modest cash incentives to use pre- and perinatal health care services.
Methods for Identifying Health Research Gaps, Needs, and Priorities: A Scoping Review 2021

Eunice C. Wong, Alicia Ruelaz Maher, Aneesa Motala, Rachel Ross, Goke Akinniranye, Jody Larkin, Susanne Hempel
The purpose of this review is to characterize methods conducted or supported by research funding organizations to identify health research gaps, needs, or priorities.
Working Hard or Hardly Working: Health Worker Effort and Health Outcomes 2021

Edward N. Okeke
Effort by health workers in developing countries has been the subject of recent attention, but the implications for health outcomes have remained a matter of conjecture. This paper provides new evidence about the returns to health worker effort.
Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment 2021

Justin W. Timbie, Alice Y. Kim, Thomas W. Concannon
Use of real-world evidence in FDA processes has the potential to contribute important evidence to drug approval processes.
A Comparison of Approaches to Identify Live Births Using the Medicaid Analytic eXtract 2021

Sara E. Heins, Laura J. Faherty, Ashley M. Kranz
This study described and validated five approaches to identifying births using Medicaid data.
In Nigeria, Stillbirths And Newborn Deaths Increased During The COVID-19 Pandemic 2021

Edward N. Okeke, Isa Sadeeq Abubakar, Rebecca De Guttry
COVID-19 increased the number of stillbirths and newborn deaths in Nigeria.
Association Between COVID-19 Relief Funds and Hospital Characteristics in the US 2021

Jonathan Cantor, Nabeel Qureshi, Brian Briscombe, Justin Chapman, Christopher M. Whaley
CARES Act funds may have disproportionately gone to hospitals that were in a stronger financial situation prior to the pandemic compared to those that were not.
Serious Illness Survey for Home-Based Programs: Spanish-Language Version 2021

Melissa A. Bradley, Rebecca Anhang Price, Deborah Kim
RAND Corporation researchers developed and field-tested a survey to assess the experiences of individuals who receive care from programs that provide serious illness care to patients in their homes. This is the Spanish version of the survey tool.
Serious Illness Survey for Home-Based Programs 2021

Rebecca Anhang Price, Melissa A. Bradley, Danielle Schlang
RAND Corporation researchers developed and field-tested a survey to assess the experiences of individuals who receive care from programs that provide serious illness care to patients in their homes.
Practice Expense Data Collection and Methodology: Phase II Final Report 2021

Lane F. Burgette, Joachim O. Hero, Jodi L. Liu, Catherine C. Cohen, Barbara O. Wynn, Katie Merrell, Drew M. Anderson, Daniel J. Crespin, Stephanie Dellva, Roald Euller, et al.
In this report, the authors address how the Centers for Medicare & Medicaid Services (CMS) might improve the methodology used in practice expense (PE) rate-setting, update data that inform PE rates, or both. The system of data and methods that CMS uses to support PE rate-setting is complex; thus, CMS must take into account a number of competing priorities when considering changes to the system.
Adjusting Medicare Advantage Star Ratings for Socioeconomic Status and Disability 2021

Melony E. Sorbero, Susan M. Paddock, Cheryl L. Damberg, Ann C. Haas, Mallika Kommareddi, Anagha Alka Tolpadi, Megan Mathews, Marc N. Elliott
We examine the impact of socioeconomic status and disability adjustments on Medicare Advantage plans' and prescription drug plans' contract star ratings.
Shifting From Passive Quality Reporting to Active Nudging to Influence Consumer Choice of Health Plan 2021

Amelia Haviland, Cheryl L. Damberg, Megan Mathews, Susan M. Paddock, Marc N. Elliott
We assess the impacts of CMS' targeted quality-based nudges with longitudinal analysis of 2009–2014 Medicare Advantage plan enrollment trends.
Assessing Relationships Between Drug Shortages in the United States and Other Countries 2021

Andrew W. Mulcahy, Preethi Rao, Vishnupriya Kareddy, Denis Agniel, Jonathan S. Levin, Daniel Schwam
Drug shortages, which occur when the supply of drugs does not meet the demand, are a persistent policy and public health concern in the United States and in other countries. The authors assess whether U.S. drug shortages result in (1) measurable changes in U.S. volume, price, and other metrics, and (2) measurable changes in the same outcomes in other countries. They found that most U.S. shortages appear to be domestic in scope.
Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships 2021

Andrew W. Mulcahy, Vishnupriya Kareddy
The authors describe the stakeholders involved in prescription drug supply chains and the flows of products, payments, and information between stakeholders. Many stakeholders and steps are involved in the life cycle of a prescription drug as it moves from chemical synthesis and formulation through dispensing or administration to patients.
Use of Buprenorphine for Those with Employer-Sponsored Insurance During the Initial Phase of the COVID-19 Pandemic 2021

Jonathan Cantor, Andrew W. Dick, Rebecca Lee Haffajee, Megan F. Pera, Dena M. Bravata, Bradley D. Stein, Christopher M. Whaley
This study examined changes in the use of buprenorphine to treat opioid use disorder in 2020 during the onset of the COVID-19 pandemic using pharmaceutical claims.
Population-Based Estimates of Geographic Accessibility of Medication for Opioid Use Disorder by Substance Use Disorder Treatment Facilities from 2014 to 2020 2021

Jonathan Cantor, David Powell, Aaron Kofner, Bradley D. Stein
This cross-sectional study of substance use disorder treatment facilities examined the national share of facilities that offer medication treatment for opioid use disorder (MOUD) and population-based measures of geographic accessibility of facilities offering MOUD.
Trends in Visits to Substance Use Disorder Treatment Facilities in 2020 2021

Jonathan Cantor, David Kravitz, Mark J. Sorbero, Barbara Andraka-Christou, Christopher M. Whaley, Kathryn E. Bouskill, Bradley D. Stein
This study examined weekly changes in the number of substance use disorder treatment facility visits in 2020 compared to 2019, and explored variation in change in weekly visits by COVID-19 incidence and historical fatal drug overdose rate.
Neonatal Opioid Withdrawal Syndrome Is Associated With Infant Foster Care Entry At The County Level 2021

Sarah F. Loch, Bradley D. Stein, Robin Ghertner, Elizabeth McNeer, William D. Dupont, Rosanna Smart, Stephen W. Patrick
This study used a decade of data from U.S. counties to examine how rates of neonatal opioid withdrawal syndrome (NOWS) and county-level characteristics were associated with entry in the child welfare system.

Page 1 of 3
1
2
3
Next